Search ZEOX
Zeo ScientifiX, Inc.
OTC · CIK 1557376
Last close1.25
Daily change+0.05 (4.17%)
10 Years gain-93.99%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ZEOX · STANDARD
SIC 2836 · Biological Products, (No Diagnostic Substances) · Fiscal year end 0630
Fundamental
47.1Momentum
100.0Acceleration
100.0Confidence
63.0Annual Revenue15
Quarterly Revenue51
Annual CFO15
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth7.7 / 25
Quality9.2 / 25
Capital Efficiency12.5 / 20
Balance Sheet7.7 / 15
Shareholder Economics10.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 40.3488 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Heavy share dilution · HIGHDiluted share count increased 22.2647%.
Low interest coverage · HIGHInterest coverage is -74.6923x.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM45.14%OK
Revenue CAGR 3Y-7.13%OK
Gross Margin80.08%OK
Operating Margin-74.9%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Y3,304.86%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y22.26%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 FY Oct 31, 2025 | $5.20M | $4.27M | -$5.39M | -$718,000.00 | -$741,000.00 | 82.09% | -103.6% | -14.25% | n/a | 6.41M |
| 2024 FY Oct 31, 2024 | $4.62M | $3.78M | -$5.32M | -$1.45M | n/a | 81.73% | -115.13% | n/a | n/a | 6.34M |
| 2024 FY Oct 31, 2023 | $4.56M | $4.05M | -$6.77M | -$2.20M | -$2.22M | 88.85% | -148.49% | -48.77% | n/a | 7.03M |
| 2023 FY Oct 31, 2022 | $6.49M | $5.74M | -$8.84M | -$3.17M | -$3.99M | 88.39% | -136.23% | -61.48% | n/a | 5.69M |
| 2022 FY Oct 31, 2021 | $5.60M | $5.05M | -$12.74M | -$2.68M | -$3.11M | 90.21% | -227.68% | -55.47% | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $6.48M | sum latest 4 fiscal quarters Revenue | OK | 0001829126-26-006486, 0001829126-25-007398 |
| Revenue Growth TTM | 45.14% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001829126-26-006486, 0001829126-25-007398 |
| Revenue CAGR 3Y | -7.13% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001829126-26-000763 |
| Revenue CAGR 5Y | 122.45% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001829126-26-000763 |
| Gross Profit CAGR 3Y | -9.39% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001829126-26-000763 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001829126-26-006486, 0001829126-25-007398 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 80.08% | Gross Profit / Revenue | OK | 0001829126-26-006486, 0001829126-25-007398 |
| Operating Margin | -74.9% | Operating Income / Revenue | OK | 0001829126-26-006486, 0001829126-25-007398 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001829126-26-006486 |
| Interest Coverage | -74.69x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 1.05x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 7.47x | (Cash + Short-term Investments) / Total Debt | OK | 0001829126-26-006486 |
| Revenue per Diluted Share | $0.84 | Revenue / Diluted Shares | OK | 0001829126-26-006486, 0001829126-25-007398 |